Warfarin monitoring: Point-of-care INR testing limitations and interpretation of the prothrombin time

Journal of Thrombosis and Thrombolysis

Volumn 25, Issue 1, 2008, Pages 10-11

  Jacobson, Alan K ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

BLOOD CLOTTING TEST; CEREBROVASCULAR ACCIDENT; CONFERENCE PAPER; DRUG MONITORING; DRUG SAFETY; DRUG USE; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; PATIENT MONITORING; PATIENT SAFETY; POINT OF CARE TESTING; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK REDUCTION; THROMBOEMBOLISM;

DRUG MONITORING; HUMANS; INTERNATIONAL NORMALIZED RATIO; POINT-OF-CARE SYSTEMS; PROTHROMBIN TIME; WARFARIN;

EID: 38049151214     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-007-0098-5     Document Type: Conference Paper

References (3)

1. Horsti J, Uppa H, Vilpo J (2005) Poor agreement among prothrombin time international normalized ratio methods: Comparison of seven commercial reagents. Clin Chem 51:553-560
2. Kaatz SS, White RH, Hill J et al (1995) Accuracy of laboratory and portable monitor international normalized ratio determinations: comparison with a criterion standard. Arch Inter Med 155:1861-1867
3. Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV et al (2003) Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. New Engl J Med 349(11):1019-1026